Atıf Formatları
Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

I. V. Bayoglu Et Al. , "Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.17, pp.7119-7123, 2014

Bayoglu, I. V. Et Al. 2014. Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.17 , 7119-7123.

Bayoglu, I. V., Varol, U., Yildiz, İ., Muslu, U., Alacacioglu, A., Kucukzeybek, Y., ... Akyol, M.(2014). Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.17, 7119-7123.

Bayoglu, Ibrahim Et Al. "Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.17, 7119-7123, 2014

Bayoglu, Ibrahim V. Et Al. "Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.17, pp.7119-7123, 2014

Bayoglu, I. V. Et Al. (2014) . "Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.17, pp.7119-7123.

@article{article, author={Ibrahim Vedat Bayoglu Et Al. }, title={Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2014, pages={7119-7123} }